Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Lemaitre Vascular Inc

Lemaitre Vascular Inc (LMAT)

Market is closed
News
Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy?

Is LeMaitre Vascular Inc (LMAT) A Good Stock To Buy?

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively...

Keep Reading →

May 9th, 2019 - Hedge Funds News

Top 75 Healthcare Dividend Stocks To Invest In

Top 75 Healthcare Dividend Stocks To Invest In

Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.

Keep Reading →

July 17th, 2017 - Dividend Stocks News

How LeMaitre Vascular Inc (LMAT) Stacks Up Against Its Peers

How LeMaitre Vascular Inc (LMAT) Stacks Up Against Its Peers

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.

Keep Reading →

December 13th, 2016 - Hedge Funds News

Hedge Funds Are Buying LeMaitre Vascular Inc (LMAT)

Hedge Funds Are Buying LeMaitre Vascular Inc (LMAT)

After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...

Keep Reading →

December 13th, 2015 - Hedge Funds News

LeMaitre Vascular Inc (LMAT), Boston Scientific Corporation (BSX) - The Race In Medical Device Industry: Who Is The Winner?

LeMaitre Vascular Inc (LMAT), Boston Scientific Corporation (BSX) - The Race In Medical Device Industry: Who Is The Winner?

LeMaitre Vascular Inc (NASDAQ:LMAT), a global provider of disposable and implantable vascular devices, recently made an acquisition of privately-owned Clinical Instruments.

Keep Reading →

July 19th, 2013 - News

BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?

BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012. BIOL shareholders have witnessed a decrease in enthusiasm from smart money in recent months.

Keep Reading →

April 29th, 2013 - News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)